Recombinant multi-species RPS27A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPS27A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Ubiquitin, a highly conserved protein that has a major role in targeting cellular proteins for degradation by the 26S proteosome, is synthesized as a precursor protein consisting of either polyubiquitin chains or a single ubiquitin fused to an unrelated protein. This gene encodes a fusion protein consisting of ubiquitin at the N terminus and ribosomal protein S27a at the C terminus. When expressed in yeast, the protein is post-translationally processed, generating free ubiquitin monomer and ribosomal protein S27a. Ribosomal protein S27a is a component of the 40S subunit of the ribosome and belongs to the S27AE family of ribosomal proteins. It contains C4-type zinc finger domains and is located in the cytoplasm. Pseudogenes derived from this gene are present in the genome. As with ribosomal protein S27a, ribosomal protein L40 is also synthesized as a fusion protein with ubiquitin; similarly, ribosomal protein S30 is synthesized as a fusion protein with the ubiquitin-like protein fubi. Multiple alternatively spliced transcript variants that encode the same proteins have been identified.[provided by RefSeq, Sep 2008]
The Alternative Names of target: 0610006J14Rik,CEP80,HEL112,RPS27A,Rps27a,S27A,UBA80,UBC,UBCEP1,UBCEP80,Uba52,Ubb,Ubc,Ubiquitin carboxyl extension protein 80,Ubiquitin-ribosomal protein eS31 fusion protein,eS31
Go
to RPS27A products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP11017-Ag-1/ GM-Tg-hg-IP11017-Ag-2 | Human RPS27A protein | Human |
| GM-Tg-rg-IP11017-Ag-1/ GM-Tg-rg-IP11017-Ag-2 | Rat RPS27A protein | Rat |
| GM-Tg-mg-IP11017-Ag-1/ GM-Tg-mg-IP11017-Ag-2 | Mouse RPS27A protein | Mouse |
| GM-Tg-cynog-IP11017-Ag-1/ GM-Tg-cynog-IP11017-Ag-2 | Cynomolgus/Rhesus macaque RPS27A protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP11017-Ag-1/ GM-Tg-felg-IP11017-Ag-2 | Feline RPS27A protein | Feline |
| GM-Tg-cang-IP11017-Ag-1/ GM-Tg-cang-IP11017-Ag-2 | Canine RPS27A protein | Canine |
| GM-Tg-bovg-IP11017-Ag-1/ GM-Tg-bovg-IP11017-Ag-2 | Bovine RPS27A protein | Bovine |
| GM-Tg-equg-IP11017-Ag-1/ GM-Tg-equg-IP11017-Ag-2 | Equine RPS27A protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP11017-Ag-1/ GM-Tg-hg-IP11017-Ag-2;
GM-Tg-rg-IP11017-Ag-1/ GM-Tg-rg-IP11017-Ag-2;
GM-Tg-mg-IP11017-Ag-1/ GM-Tg-mg-IP11017-Ag-2; GM-Tg-cynog-IP11017-Ag-1/ GM-Tg-cynog-IP11017-Ag-2; GM-Tg-felg-IP11017-Ag-1/ GM-Tg-felg-IP11017-Ag-2; GM-Tg-cang-IP11017-Ag-1/ GM-Tg-cang-IP11017-Ag-2; GM-Tg-bovg-IP11017-Ag-1/ GM-Tg-bovg-IP11017-Ag-2; GM-Tg-equg-IP11017-Ag-1/ GM-Tg-equg-IP11017-Ag-2 |
| Products Name | RPS27A protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | RPS27A |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPS27A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.